Fairfax Plus Media Inc. image ad
See all Fairfax Plus Media Inc. ads →
Aug 19, 2026
Paid Advertisement on Behalf of LIR Life Sciences Corp. (CSE: SKNY | FSE: N790 | OTCPK: BBCMF)
thesunriseinvestor.com
Non-Injectable GLP-1 Technology for Obesity Treatment
LIR Life Sciences is developing next-generation drug delivery for GLP-1 obesity therapies—without the needle. Positioned at the forefront of emerging treatment trends.
Reach
6.8K
Est. spend
$102
Ran for
8d
Format
image
Platforms
A world of creative inspiration
Your next great ad
starts with an idea.
Explore 13.5M+ ads in Admanage. Find fresh angles, follow the brands that inspire you, and save your next campaign’s starting point.
Join Admanage
Discover new ideasBuild your swipe fileExplore brands you love